Ginkgo Bioworks
DNA
DNA
278 hedge funds and large institutions have $2.74B invested in Ginkgo Bioworks in 2022 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 101 increasing their positions, 55 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
7% more funds holding
Funds holding: 260 → 278 (+18)
0.04% more ownership
Funds ownership: 1.8% → 1.84% (+0.04%)
50% less funds holding in top 10
Funds holding in top 10: 8 → 4 (-4)
Holders
278
Holding in Top 10
4
Calls
$35.3M
Puts
$19.4M
Top Buyers
| 1 | +$233M | |
| 2 | +$123M | |
| 3 | +$46.9M | |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
+$29M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$28.5M |
Top Sellers
| 1 | -$116M | |
| 2 | -$22.9M | |
| 3 | -$18.9M | |
| 4 |
Goldman Sachs
New York
|
-$9.85M |
| 5 |
Millennium Management
New York
|
-$9.19M |